Growth Metrics

Merck (MRK) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 43.66%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 11.49%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 8.59%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 3,250.86%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 22.98%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 4.00%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 5.75%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 6.17%
10 Gsk 88.34 Bn 83.66 Bn - 4.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3,250.86%
Dec 31, 2025 6.46%
Sep 30, 2025 9.35%
Jun 30, 2025 8.68%
Mar 31, 2025 -96.71%
Dec 31, 2024 3.16%
Sep 30, 2024 4.08%
Jun 30, 2024 4.45%
Mar 31, 2024 5.92%
Dec 31, 2023 7.60%
Sep 30, 2023 10.29%
Jun 30, 2023 10.83%
Mar 31, 2023 10.18%
Dec 31, 2022 11.12%
Sep 30, 2022 10.01%
Jun 30, 2022 11.04%
Mar 31, 2022 7.94%
Dec 31, 2021 13.41%
Sep 30, 2021 9.73%
Jun 30, 2021 14.41%
Mar 31, 2021 19.82%
Dec 31, 2020 18.91%
Sep 30, 2020 18.42%
Jun 30, 2020 13.90%
Mar 31, 2020 13.05%
Dec 31, 2019 7.57%
Sep 30, 2019 12.01%
Jun 30, 2019 9.79%
Mar 31, 2019 7.52%
Dec 31, 2018 6.85%
Sep 30, 2018 4.64%
Jun 30, 2018 4.40%
Mar 31, 2018 4.31%
Dec 31, 2017 3.43%
Sep 30, 2017 1.33%
Jun 30, 2017 0.89%
Mar 31, 2017 -2.57%
Dec 31, 2016 -3.85%
Sep 30, 2016 -3.63%
Jun 30, 2016 -5.09%
Mar 31, 2016 -4.26%
Dec 31, 2015 -4.79%
Sep 30, 2015 -7.11%
Jun 30, 2015 -9.09%
Mar 31, 2015 -9.70%
Dec 31, 2014 -12.27%
Sep 30, 2014 -12.30%
Jun 30, 2014 -11.41%
Dec 31, 2013 -6.59%
Jun 30, 2013 -1.16%
Dec 31, 2012 -1.64%
Jun 30, 2012 -4.82%
Mar 31, 2012 -4.21%
Dec 31, 2011 -4.60%
Sep 30, 2011 -4.28%
Jun 30, 2011 -3.83%
Mar 31, 2011 -6.41%
Dec 31, 2010 -6.55%
Sep 30, 2010 147.20%
Jun 30, 2010 152.21%